National Institute of Allergy and Infectious Diseases, National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

NIAID Research Funding

NIAID Funding News
icon Subscribe to Alerts
Editorial Board
News Links
Opportunities and Announcements
Paylines and Budget
Grants and Contracts
Council
Extramural SOPs
Questions and Answers
Glossary
Find It! Index
Latest Updates
icon Subscribe to Alerts
Search in Research Funding

June 18, 2007

News Articles

Opportunities and Resources

Advice Corner

New Funding Opportunities

News Articles
Separator line

Progress on NIH's FY 2008 Budget

We're one more step along the road from the President's Budget request to a final FY 2008 budget. The House subcommittee that covers NIH has finished its markup for the President's Budget.

The Subcommittee on Labor, Health and Human Services, Education, and Related Agencies recommended these key points:

  • NIH's budget would increase to $29.4 billion, $1 billion more than the FY 2008 President's Budget request.
    • NIH's Office of the Director would get $597 million of the $1 billion, including $374 million for the NIH Common Fund.
    • The other $403 million would give most ICs, including NIAID, 1.5 percent more than in FY 2007. 
  • NIAID's FY 2008 research budget would increase by $63 million.
  • NIAID would also get $300 million to pass through to the Global Fund to Fight HIV/AIDS, Tuberculosis, and Malaria.

In the next step, the full House committee will make a budget proposal. Read more about the budget process starting at Planning and Budget Cycle.

We covered the President's Budget request in more detail in our March 13 article, Level Budgets on the Horizon Next Fiscal Year.

Separator line

New Investigators, New Tutorial

Hot off the virtual presses, NIAID's New Investigator Guide to NIH Funding advises new applicants on grant-getting strategies and provides basic information about NIH funding. Part of our All About Grants series, this tutorial and our New Investigator Portal should help neophytes navigate the application process.

Despite the constraints on NIH budgets, it's a relatively good time to be a new investigator. NIH and NIAID want to fund more new scientists and have created special programs and funding approaches to meet that goal.

Note that if you compare the new tutorial with some of the other All About Grants tutorials, you may see overlapping content while we reorganize.

Separator line

NIAID's Division of AIDS Seeks a New Director

Are you an exceptional and visionary leader in the field of AIDS and HIV research? If you have the right mix of science administration and executive leadership skills, you could become the director of NIAID's Division of AIDS.

See the Position Announcement for a detailed description and how to apply. Application packages are due by August 24, 2007. If you have questions, contact Ms. Lisa Poindexter-Steed at lsteed@niaid.nih.gov or 301/496-9687.

Separator line

NIAID Director Wins Two Medals for Scientific Achievement

NIAID Director Anthony S. Fauci, M.D., recently received two prestigious national awards for his scientific accomplishments.

Last month, Dr. Fauci became the first staff member from NIAID to earn the National Medal of Science, and the sixth from NIH. He won this recognition for his investigations of the human immune system and the pathogenesis of HIV. Congress established the National Medal of Science in 1959 to recognize outstanding scientific accomplishments.

In April, Dr. Fauci was awarded the 2007 George M. Kober Medal from the Association of American Physicians for his contributions to academic medicine. The Kober Medal recognizes physician-scientists in the U.S. as leaders in internal medicine. For more information, check out the April 15, 2007, NIAID news release about the award.

Separator line

New National Academy of Sciences Member

We'd like to congratulate Thomas Wellems, M.D., Ph.D., a new member of the National Academy of Sciences.

Dr. Wellems is chief of NIAID's intramural Laboratory of Malaria and Vector Research. The Academy elected Dr. Wellems for his body of work, which includes the discovery of drug resistance mechanisms in malaria.

Separator line

Familiar Faces in New Places

Congratulations to current and returning NIAID staffers who've earned two key positions.

The Division of AIDS is pleased to announce the promotion of Edward Handelsman, M.D., to chief of the Pediatric Medicine Branch. Before joining DAIDS last year, Handelsman provided primary care for children with HIV and conducted clinical research at the SUNY Downstate and King County hospitals in New York.

Kevin Callahan, Ph.D., has returned to NIAID as the Office of Strategic Planning and Financial Management's new director. Dr. Callahan comes from NCI, where he led efforts to develop and execute the Institute's strategic plans, evaluation programs, and portfolio analysis activities. He had previously worked at NIAID as a scientific review officer.

Opportunities and Resources
Separator line

New Tuberculosis Site and Research Agenda

Current events have highlighted tuberculosis, one of the most deadly and prevalent diseases of the 21st century. NIAID's increasingly comprehensive Tuberculosis Web site offers Resources for Researchers and a new research agenda.

The Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) Tuberculosis Research Agenda highlights NIAID's current research, notes research gaps, and identifies six critical research areas for the future. Research in these areas could help HIV co-infected and HIV-negative people as well as children and others affected by all forms of TB.

NIAID announced the agenda on June 6 after consulting U.S. and international experts, academia, activist groups, and other government agencies.

Separator line

Learn About Humanized Rodent Models at a New Workshop

NIAID's Division of AIDS is holding a workshop to delve into the current uses and future directions for humanized rodent models in HIV/AIDS research.

Topics include research plans and the application of these models for addressing critical issues in HIV immunology, pathogenesis, and the development of therapeutics, vaccines, and microbicides.

Find agenda, registration, and other details soon at Humanized Rodent Models Workshop. The workshop will be on September 24, 2007, at the Marriott in Bethesda, Maryland.

Separator line

Making Progress on Mentored K Award? Required Sponsor's Report Will Tell

If you have a mentored career development award -- K01, K08, K23, or K25 -- you must include a sponsor's report with your progress report. Your mentor's comments help your program officer determine whether NIAID should continue your funding.

Give your mentor plenty of time to write his or her feedback on your performance. Also allow time for your signing official to email the report as an attachment or mail a hard copy. You can't send it through the Commons.

You should avoid sending it late since an incomplete progress report will delay a potential award. Remember, progress reports are due two months before the beginning of your next budget period.

For more information, see Send Us an Annual Progress Report in the NIH Grant Cycle: Application to Renewal.

Separator line

Recently Published: Jordan Report and World Health Statistics

Advice Corner
Separator line

New PureEdge Viewer for Mac

Attention Mac users: get the new PureEdge Viewer for Macintosh. It solves the problem we mentioned in our May 22, 2007, article, "Mac Applicants: PureEdge Woes and Workarounds."

Separator line

Identify the Grant When You Send Approvals

Avoid award delays -- be sure to include the title and number of the main grant application when you send us your institutional review board (IRB), institutional biosafety committee (IBC), or institutional animal care and use committee (IACUC) approvals.

When we can't associate the approval with the grant, we have had to delay awards.

Separator line

Tips for Wrapping Up a Small Business Phase I Award

If you are concluding a phase I small business award, you should remember the following points for your final report:

  • Send the report as part of your phase II application if you’re going to apply by the next small business receipt date after your phase I award ends. Otherwise, send the final report to your grants management specialist after your grant ends.
  • The final report has no page limit, but if you include it in a phase II application, the report must fit within the Research Plan’s 25-page limit.
  • There is no form to use for a small business phase I final report. Include the following information:
    • The beginning and ending dates of the award.
    • A list of key personnel who worked on the project, their titles, dates of service, and number of hours devoted to the project.
    • A summary of the specific aims.
    • A presentation of the project’s accomplishments for all years of the award.
  • Explain technical language that may not be common knowledge to a broad scientific community.

For more instructions on what to include in the report, see your Notice of Award.

New Funding Opportunities
Separator line

See these and older announcements on our NIH Funding Opportunities Relevant to NIAID.

Separator line
DHHS Logo Department of Health and Human Services NIH Logo National Institutes of Health NIAID Logo National Institute of Allergy and Infectious Diseases August 27, 2007
Home | Help | Site Index | Accessibility | Privacy Policy | Disclaimer | Web Site Links & Policies | FOIA